AF9 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of AF9 monoclonal antibodies for investigating AF9 protein functions. AF9 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AF9 protein plays a crucial role in transcriptional regulation and influences the development of hematopoietic lineages. Research has shown that AF9 significantly impacts cell proliferation and differentiation, particularly in leukemia studies. Understanding AF9 mechanisms continues to reveal new insights into cancer biology and potential therapeutic approaches. Researchers worldwide rely on AF9 monoclonal antibodies to explore cellular pathways and molecular interactions. Current studies focusing on AF9 are uncovering promising directions in cancer research and treatment strategies. AF9 monoclonal antibodies from Santa Cruz Biotechnology enable researchers to advance scientific understanding and contribute to breakthrough discoveries in cancer biology.